USANA Reports Q4 and Full Year 2025 Results

USANA Health Sciences Reports Fourth Quarter and Full Year 2025 Results and Provides Fiscal Year 2026 Outlook.

Salt Lake City, Utah – USANA Health Sciences, Inc. (NYSE: USNA), a global leader in direct selling, today announced financial results for its fiscal fourth quarter and fiscal year ended January 3, 2026.

“USANA delivered fourth quarter net sales in line with our preliminary results announced on January 12, 2026,”

said Kevin Guest, Chairman and Chief Executive Officer.

“We began to see signs of stabilization in active customer counts in our core nutritional business as net sales in this segment increased modestly sequentially, led by growth in key markets including mainland China, the United States and Canada. Meanwhile, our omnichannel brands, Hiya and Rise, posted solid year-over-year growth.”

Key Financial and Operating Results

	Q4 2025		Q4 2024		FY 2025		FY 2024
Net sales	$226.2		$213.6		$925.3		$854.5
Net (loss) earnings*	$-1.8		$4.5		$10.8		$42.0
Diluted EPS	$-0.10		$0.23		$0.58		$2.19
Adjusted diluted EPS(1)	$0.60		$0.64		$1.93		$2.59
Adjusted EBITDA(2)	$27.3		$25.5		$101.3		$110.3
USANA Active Customers	387,000		454,000		387,000		454,000
Hiya Active Monthly Subscribers	181,700		N/A		181,700		N/A

*Pretax earnings for Q4 2025 totaled $4.0 million with income tax expense of $5.8 million. The adjustment to income taxes during the period, largely as a result of one-time impairment and cost realignment charges, is about $3.1 million greater than what would have been expected using the previously expected 65% tax rate.

Net sales, Net (loss) earnings and Adjusted EBITDA figures in millions.

Net earnings, EPS and Adjusted EBITDA figures represent amounts attributable to USANA.

 

Q4 2025 Financial Performance

Consolidated Results
		Year-Over-Year	Sequentially
Net sales	$226 million	+6% *	+6% *
Net (loss)	-$1.8 million	N/A	N/A
Diluted EPS	-$0.10	N/A	N/A
Adjusted diluted EPS(1)	$0.60	-6%	N/A
Adjusted EBITDA(2)	$27.0 million	+7%	+98%

*No meaningful FX impact

Net (loss) earnings, EPS and Adjusted EBITDA figures represent amounts attributable to USANA.

 

Fiscal Year 2025 Financial Performance

Consolidated Results
Net sales	$925 million	+8% YOY
		+9% constant currency
		-$3 million YOY FX impact
Net earnings	$10.8 million	-74%
Diluted EPS	$0.58	-74%
Adjusted diluted EPS(1)	$1.93	-25%
Adjusted EBITDA(2)	$101.3 million	-8%

Net earnings, EPS and Adjusted EBITDA figures represent amounts attributable to USANA

 

Fiscal Year 2026 Outlook

• Consolidated net sales between $925 million and $1.0 billion, or flat to 8% growth.
• Net earnings between $20.3 million and $26.6 million.
• Diluted EPS between $1.11 and $1.45.
• Adjusted Diluted EPS⁽¹⁾ between $1.95 and $2.29.
• Adjusted EBITDA⁽²⁾ between $101.3 million and $109.3 million.

Mr. Guest continued,

“Fiscal 2025 net sales grew 8%, driven primarily by a full-year contribution from Hiya. Net sales in the core nutritional business declined 8%, reflecting a challenging environment for customer acquisition in key markets. Despite this challenge, we continued to execute our diversification strategy towards an omnichannel model. That strategy is designed to support growth beyond our core nutritional business as well as to restructure and modernize our business for today’s evolving marketplace. Rise Wellness generated strong momentum with sales tripling, albeit off a small base in 2024, as distribution expanded into key retail outlets. The business is on pace for a robust year of sales growth supported by the launch of Protein Pop at a large club retailer in the first quarter. Net sales outside of our core nutritional business represented 16% of consolidated net sales in 2025, up from approximately 1% in 2024. We expect this share to increase to more than 20% of consolidated net sales in fiscal 2026.”

Read the full report on USANA.com